A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children
Public ClinicalTrials.gov record NCT03959488. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children (MEDLEY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and tolerability of MEDI8897 compared to palivizumab when administered to preterm infants entering their first RSV season and children with chronic lung disease (CLD) and congenital heart disease (CHD) entering their first and second RSV season.
Study identification
- NCT ID
- NCT03959488
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 925 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 0 Years to 1 Year
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2019 (Actual)
- Primary completion
- May 3, 2021 (Actual)
- Completion
- Jan 20, 2023 (Actual)
- Last update posted
- Sep 21, 2023
2019 – 2023
United States locations
- U.S. sites
- 30
- U.S. states
- 19
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anaheim | California | 92804 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | Los Angeles | California | 90027 | — |
| Research Site | National City | California | 91950 | — |
| Research Site | Paramount | California | 90723 | — |
| Research Site | West Covina | California | 91790 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Colorado Springs | Colorado | 80922 | — |
| Research Site | Washington D.C. | District of Columbia | 20016 | — |
| Research Site | Atlanta | Georgia | 30322 | — |
| Research Site | Chicago | Illinois | 60611 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | South Bend | Indiana | 46617 | — |
| Research Site | West Des Moines | Iowa | 50266 | — |
| Research Site | Louisville | Kentucky | 40202 | — |
| Research Site | Jackson | Mississippi | 39216 | — |
| Research Site | Columbia | Missouri | 65201 | — |
| Research Site | Mineola | New York | 11501 | — |
| Research Site | Syracuse | New York | 13210 | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Greenville | North Carolina | 27834 | — |
| Research Site | Cincinnati | Ohio | 45229 | — |
| Research Site | Columbus | Ohio | 43205 | — |
| Research Site | Greenville | South Carolina | 29607 | — |
| Research Site | Corpus Christi | Texas | 78411 | — |
| Research Site | Layton | Utah | 84041 | — |
| Research Site | St. George | Utah | 84790 | — |
| Research Site | Charlottesville | Virginia | 22902 | — |
| Research Site | Seattle | Washington | 98105 | — |
| Research Site | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03959488, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 21, 2023 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03959488 live on ClinicalTrials.gov.